# Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder

> **NCT04620759** · PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Johns Hopkins University** · enrollment: 90 (estimated)

## Conditions studied

- Major Depressive Disorder
- Alcohol Use Disorder

## Interventions

- **DRUG:** Psilocybin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04620759
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2021-04-14
- **Primary completion:** 2026-03-02
- **Final completion:** 2027-03-30
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2026-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04620759

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04620759, "Psilocybin Treatment of Major Depressive Disorder With Co-occurring Alcohol Use Disorder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04620759. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*